{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:31:01Z","timestamp":1749198661582,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40744-024-00698-7","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T20:08:42Z","timestamp":1720901322000},"page":"1393-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference?"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5774-9643","authenticated-orcid":false,"given":"Silvia","family":"Scriffignano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3771-5205","authenticated-orcid":false,"given":"Fabio Massimo","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1074-0861","authenticated-orcid":false,"given":"Mauro","family":"Fatica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-2825","authenticated-orcid":false,"given":"Paola","family":"Conigliaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1343-1729","authenticated-orcid":false,"given":"Maria Sole","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"key":"698_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370. https:\/\/doi.org\/10.1056\/NEJMra1505557.","journal-title":"N Engl J Med"},{"key":"698_CR2","unstructured":"Scarpa R, Ayala F, Caporaso N, Olivieri I. Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol. 2006;33:210\u20132. PMID: 16465649."},{"key":"698_CR3","doi-asserted-by":"publisher","unstructured":"Lubrano E, Scriffignano S, Perrotta FM. Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J Rheumatol. 2019;46:1428\u201330. https:\/\/doi.org\/10.3899\/jrheum.190054. PMID: 31676545.","DOI":"10.3899\/jrheum.190054"},{"key":"698_CR4","first-page":"14","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64:14\u20137.","journal-title":"Ann Rheum Dis"},{"key":"698_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002934","volume":"9","author":"P Richette","year":"2023","unstructured":"Richette P, Vis M, Ohrndorf S, et al. Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-na\u00efve population of patients with PsA. RMD Open. 2023;9: e002934.","journal-title":"RMD Open"},{"key":"698_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S2665-9913(23)00274-6","volume":"5","author":"E Lubrano","year":"2024","unstructured":"Lubrano E, Perrotta FM. Sex-related differences in psoriatic arthritis. Lancet Rheumatol. 2024;5:699\u2013701.","journal-title":"Lancet Rheumatol"},{"key":"698_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S2665-9913(23)00264-3","volume":"5","author":"L Eder","year":"2024","unstructured":"Eder L, Mylvaganam S, Pardo Pardo J, et al. Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis. Lancet Rheumatol. 2024;5:716\u201327.","journal-title":"Lancet Rheumatol"},{"key":"698_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40744-023-00535-3","volume":"10","author":"E Lubrano","year":"2023","unstructured":"Lubrano E, Scriffignano S, Fatica M, et al. Psoriatic arthritis in males and females: differences and similarities. Rheumatol Ther. 2023;10:589\u201399. https:\/\/doi.org\/10.1007\/s40744-023-00535-3.","journal-title":"Rheumatol Ther"},{"key":"698_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41583-020-0310-6","volume":"21","author":"JS Mogil","year":"2020","unstructured":"Mogil JS. Qualitative sex differences in pain processing: emerging evidence of a biased literature. Nat Rev Neurosci. 2020;21:353\u201365. https:\/\/doi.org\/10.1038\/s41583-020-0310-6.","journal-title":"Nat Rev Neurosci"},{"key":"698_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001170","volume":"6","author":"E Lubrano","year":"2020","unstructured":"Lubrano E, Scriffignano S, Azuaga AB, et al. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices. RMD Open. 2020;6: e001170. https:\/\/doi.org\/10.1136\/rmdopen-2020-001170.","journal-title":"RMD Open"},{"key":"698_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/rheumatology\/kez202","volume":"59","author":"JZ Fei","year":"2020","unstructured":"Fei JZ, Perruccio AV, Ye JY, Gladman DD, Chandran V. The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis. Rheumatology (Oxford). 2020;59:69\u201376. https:\/\/doi.org\/10.1093\/rheumatology\/kez202.","journal-title":"Rheumatology (Oxford)"},{"key":"698_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175737","volume":"12","author":"GS Rovner","year":"2017","unstructured":"Rovner GS, Sunnerhagen KS, Bj\u00f6rkdahl A, Gerdle B, B\u00f6rsbo B, Johansson F, Gillanders D. Chronic pain and sex-differences; women accept and move, while men feel blue. PLoS ONE. 2017;12: e0175737. https:\/\/doi.org\/10.1371\/journal.pone.0175737.","journal-title":"PLoS ONE"},{"key":"698_CR13","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.3899\/jrheum.150595","volume":"42","author":"E Lubrano","year":"2015","unstructured":"Lubrano E, Perrotta FM, Parsons WJ, Marchesoni A. Patient\u2019s global assessment as an outcome measure for psoriatic arthritis in clinical practice: a surrogate for measuring low disease activity? J Rheumatol. 2015;42:2332\u20138. https:\/\/doi.org\/10.3899\/jrheum.150595.","journal-title":"J Rheumatol"},{"issue":"Suppl 10","key":"698_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/acr.24242","volume":"72","author":"A Ogdie","year":"2020","unstructured":"Ogdie A, Coates LC, Mease P. Measuring outcomes in psoriatic arthritis. Arthritis Care Res (Hoboken). 2020;72(Suppl 10):82\u2013109. https:\/\/doi.org\/10.1002\/acr.24242.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00698-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-024-00698-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00698-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T21:05:47Z","timestamp":1727211947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-024-00698-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s40744-024-00698-7","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"type":"print","value":"2198-6576"},{"type":"electronic","value":"2198-6584"}],"subject":[],"published":{"date-parts":[[2024,7,13]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Silvia Scriffignano, Fabio Massimo Perrotta, Muaro Fatica, Paola Conigliaro, Maria Sole Chimenti and Ennio Lubrano have nothing to disclose. Fabio Massimo Perrotta and Ennio Lubrano are members of the Editorial Board of <i>Rheumatology and Therapy<\/i> and were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed written consent was obtained from all individual participants included in the study. The study was approved by the Institutional Review Board of the University of Molise (protocol no. 0001-017-2021), which provided the approval for both centers (the University of Molise and the University of Tor Vergata).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}